Cytokines, peptide hormones, and neurotransmitters, as well as their receptors, are endogenous to the brain, endocrine, and immune system (1, 9, 27) , indicating that the immune and neuroendocrine system represents an integrated information circuit. In contrast, the healthy brain is believed to be an immunological privileged site since the brain is able to exclude components of the immune system by the blood-brain barrier (1, 9, 27) . Since the brain has specialized cells that produce cytokines and execute immunological effector functions, the brain appears to have a unique mechanism of immune responses. When infection occurs in the brain, lymphocytes infiltrate the organ. Therefore, it is possible that lymphoid cells, the regular components of the immune system, and the specialized cells in the brain for immune responses cooperate in host defense against infection in this organ. However, the mechanism of host defense in the brain remains to be defined.
Toxoplasma gondii, an obligate intracellular protozoan parasite, has provided an excellent model for investigating the mechanism of host defense in the brain. During the acute stage of infection, tachyzoites proliferate within various cells; thereafter, the parasite forms cysts in the brain and establishes a chronic (latent) infection. Persistence of the chronic infection in the brain has been shown to require the host immune system. In immunocompromised individuals, reactivation of the infection may occur and result in life-threatening toxoplasmic encephalitis (TE) (21, 43) . However, the mechanism by which the immune system maintains a latent chronic T. gondii infection in the brain remains unclear. Murine models have been used to study the mechanism of host resistance against development of TE. Immune responses mediated by gamma interferon (IFN-␥) (13, 33, 34, 37) , tumor necrosis factor alpha (4, 13, 35, 44) , and inducible nitric oxide synthase (17, 31) have been shown to be required for prevention of TE, although antibodies are also involved in the resistance (11, 22) . However, each of these studies was performed in strains of mice (C57BL/6 and CBA/Ca) that are genetically susceptible to development of TE and eventually develop progressive and ultimately fatal TE without immunosuppressive treatment (2, 35, 36) . In these animals, active infection with tachyzoites appears to continue in the brain during the entire period of infection. Therefore, these animals do not appear to be ideal models for analyzing the mechanism of host resistance to prevent reactivation of a latent (cyst) infection.
In contrast to genetically susceptible strains, genetically resistant strains (e.g., BALB/c) are able to control T. gondii infection in the brain and develop a latent chronic infection as do immunocompetent humans (2, 35, 36) . Recently, we developed a murine model of reactivation of T. gondii infection in the brain using infected, sulfadiazine-treated BALB/c-background IFN-␥-knockout (IFN-␥ Ϫ/Ϫ ) mice (37) . In the present study, we investigated the mechanism of prevention of reactivation of T. gondii infection by using adoptive transfer of immune T cells into infected, sulfadiazine-treated immunodefi-cient animals including athymic nude, SCID, and IFN-␥ Ϫ/Ϫ mice. We found that the IFN-␥ production by non-T cells, in addition to T cells, play a critical role in prevention of reactivation of T. gondii infection in the brain.
MATERIALS AND METHODS
Mice. Female BALB/c-background IFN-␥ Ϫ/Ϫ , athymic nude, SCID, and control BALB/c mice were obtained from The Jackson Laboratory (Bar Harbor, Main). Female Swiss Webster mice were from Taconic Farms (Germantown, N.Y.). Mice were 6 to 8 weeks old when used. There were three to six mice in each experimental group.
Infection with T. gondii. Cysts of the ME49 strain were obtained from brains of Swiss Webster mice that had been infected intraperitoneally with 10 cysts for 2 to 3 months. Mice were sacrificed by asphyxiation with CO 2 , and their brains were removed and triturated in phosphate-buffered saline (pH 7.2) (39). An aliquot of the brain suspension was examined for numbers of cysts, and after appropriate dilution in phosphate-buffered saline, animals were infected with 10 cysts perorally by gavage. Mice were treated with sulfadiazine in drinking water (400 mg/liter) beginning 4 days (for IFN-␥ Ϫ/Ϫ mice) or 7 days (for nude and SCID mice) after infection for 3 weeks.
Histopathology. At 5 or 7 days after discontinuation of treatment with sulfadiazine, mice were euthanized by asphyxiation with CO 2 . Their brains were removed and immediately fixed in a solution containing 10% formalin, 70% ethanol, and 5% acetic acid. Two to four 5-m-thick sagittal sections (50 or 100 m between sections) of the brain from each mouse were stained with hematoxylin and eosin. Immunoperoxidase staining using rabbit immunoglobulin G antibody against tachyzoite-specific SAG2 was used for detection of tachyzoites (3, 23, 37) . The specificity of the antibody was described previously (28) . Sections stained with hematoxylin and eosin were evaluated for inflammatory changes. Sections stained by the immunoperoxidase method were evaluated for the numbers of areas of inflammation associated with tachyzoites.
Transfer of immune spleen cells and T cells. Control BALB/c mice infected perorally with 10 cysts for 2 to 3 months were challenged intraperitoneally with 100 cysts. One week after the challenge infection, spleen cells were obtained from two or three mice, suspended in Hanks' balanced salt solution, and pooled. A total of 2 ϫ 10 7 immune spleen cells were injected intravenously from a tail vein to recipient IFN-␥ Ϫ/Ϫ , nude, or SCID mice at 9 and 2 days before discontinuation of treatment with sulfadiazine. CD4 ϩ and CD8 ϩ T-cell subsets of the immune spleen cells were purified by treating the spleen cells with either magnetic beads-conjugated anti-mouse CD4 (GK 1.5) or anti-mouse CD8 (53-6.7) monoclonal antibody (MAbs) (Miltenyi Biotec, Sunnyvale, Calif.). The purity of the T-cell subset in each of the purified preparations was Ͼ98%. Total T-cell population was purified from immune spleen cells by applying both anti-CD4 and anti-CD8 MAbs together. For adoptive transfer of the purified T cells, 10 7 of the cells were injected intravenously to nude mice in the same manner as a transfer of immune spleen cells. In some experiments, immune spleen cells were obtained from IFN-␥ Ϫ/Ϫ mice that had been infected and treated with sulfadiazine for 3 weeks.
Depletion of NK cells. Infected SCID mice were injected intraperitoneally with 100 l of rabbit anti-asialo GM1 antiserum (Wako Pure Chemical Industries Ltd., Osaka, Japan) every 3 days beginning 10 day before discontinuation of sulfadiazine treatment. As a control, mice were injected with normal rabbit serum in the same manner.
Flow cytometry. At the last day of treatment with sulfadiazine or 7 days after discontinuation of the treatment, mononuclear cells infiltrated into brains or spleen cells of infected SCID mice treated or untreated with anti-asialo GM1 antibody were obtained as described previously (40) . The mononuclear cells (10 6 ) were pretreated on ice for 10 min with 10 l of a predetermined optimal concentration of anti-Fc␥II/III receptors (2.4G2) to block non-antigen-specific binding of antibodies to the Fc␥II/III receptors. Thereafter, the cells were incubated on ice for 30 min with 10 l of optimal concentrations of phycoerythrinconjugated anti-pan NK cell MAb (clone DX5; PharMingen, San Diego, Calif.). Analysis of stained cells was performed with a FACScan (Becton Dickinson, Mountain View, Calif.). Dead cells were gated out on the basis of propidium iodide staining.
Semiquantitative reverse transcription-PCR (RT-PCR) for detection of mRNA for IFN-␥. At the last day of sulfadiazine treatment, RNA was isolated from brains of infected mice by using RNA STAT-60 (TEL-TEST "B", Inc., Friendswood, Tex.) as instructed by the manufacturer. cDNA was synthesized using the RNA as described previously (35, 42) . PCR for ␤-actin and IFN-␥ was performed with 5 l of 1:10 dilution of the original cDNA reaction mixture with a GeneAmp 9700 thermocycler (Perkin-Elmer, Emeryville, Calif.), using 30 cycles to produce an amount of DNA within a linear range as described previously (35, 42) . This number of cycles was determined in preliminary studies using different amounts of cDNA of the sample. Specific primers for ␤-actin and IFN-␥ (Clontech, Palo Alto, Calif.) designed to span at least one intron allowed differentiation of amplified target DNA derived from either cDNA or genomic DNA in the PCR.
Homology of PCR products to the predicted transcript sequence was examined by Southern blot analysis. Ten-microliter aliquots of the final PCR mixtures were electrophoresed at 100 V for 1 h on a 1.5% agarose gel and denatured (35, 42) . The DNA was then transferred to a Duralon-UV membrane (Stratagene, La Jolla, Calif.) by the standard blotting procedure (30) and UV cross-linked. Oligonucleotide probes for ␤-actin and IFN-␥ (Clontech) which hybridize to the PCR products wholly within the region amplified by the primers were end labeled as described for the 3Ј-end labeling and signal amplification system for a FluorImager (Amersham, Little Chalfont, England), and hybridization was detected by scanning of the membranes with a FluorImager Storm 860 (Molecular Dynamics, Sunnyvale, Calif.) as described previously (40) . Quantification of mRNA was performed by densitometry analysis with the FluorImager and normalized to the ␤-actin level.
Statistical analysis. Levels of significance for numbers of areas associated with tachyzoites in the brain were determined by the Student t, alternate Welch t, or Wilcoxon rank sum test. The alternative Welch t test was applied when standard deviations were significantly different between groups tested. The Wilcoxon rank sum test was applied when the standard deviation was zero. Levels of significance for mortality in mice were determined using Fisher's exact test. Differences which provided P values of less than 0.05 were considered significant.
RESULTS

Effect of adoptive transfer of immune spleen cells on mortality and development of TE in infected IFN-␥
؊/؊ mice. We recently reported that IFN-␥ Ϫ/Ϫ mice that had been infected and treated with sulfadiazine developed severe TE and died after discontinuation of treatment with sulfadiazine (37). We examined whether adoptive transfer of immune spleen cells from infected control mice prevents mortality and development of TE in the IFN-␥ Ϫ/Ϫ mice. Immune spleen cells (2 ϫ 10 7 ) were injected intravenously at 9 and 2 days before discontinuation of sulfadiazine. Transfer of the immune spleen cells failed to prevent the development of TE in these animals. Mice that had received the cell transfer all died after discontinuation of sulfadiazine treatment as early as did mice that had not received the cell transfer (Fig. 1A ). Many areas of inflammation associated with tachyzoites were observed in brains of both animals with and without the cell transfer (Fig. 1C) . The brain was the only organ in which large numbers of T. gondii tachyzoites were detected in the animals with or without the cell transfer, although small numbers of the parasite were detectable in their hearts and lungs (data not shown).
Effect of adoptive transfer of immune spleen cells on mortality and development of TE in infected athymic nude and SCID mice. Since the failure of adoptive transfer of immune spleen cells to prevent the development of TE in IFN-␥ Ϫ/Ϫ mice was unexpected, we examined whether the cell transfer confers resistance to development of TE in other immunodeficient strains of mice. Athymic nude and SCID mice were infected, treated with sulfadiazine, and injected with immune spleen cells. Nude mice that had not received the cell transfer developed necrotizing TE and died after discontinuation of sulfadiazine treatment (Fig. 1B, 1C and 2B ). In contrast, nude mice that had received the immune spleen cells did not develop TE and survived (P Ͻ 0.001 for mortality and P Ͻ 0.05 for histology [Fig. 1B, 1C, and 2A] ). SCID mice that had received the immune spleen cells also did not develop TE, VOL. 69, 2001 ANTITOXOPLASMOSIS IFN-␥-PRODUCING NON-T CELLS 2921 whereas control SCID mice that had not received the cells developed severe TE (P Ͻ 0.05 [ Fig. 1C]) . Thus, adoptive transfer of immune spleen cells can confer resistance against development of TE in infected nude and SCID mice but not in IFN-␥ Ϫ/Ϫ mice. These results suggest that IFN-␥ production by non-T cells in the recipient animals is required for passively transferred immune spleen cells to demonstrate their protective activity against TE.
Expression of IFN-␥ mRNA in brains of infected nude and SCID mice. We examined whether IFN-␥ was expressed in the brains of infected, sulfadiazine-treated nude and SCID mice. Amounts of IFN-␥ mRNA in total RNA fractions obtained from brains of mice were measured by semiquantitative RT-PCR at the last day of sulfadiazine treatment without adoptive transfer of immune spleen cells. mRNA for IFN-␥ was detected in brains of either of these animals (Fig. 3) . In contrast, IFN-␥ mRNA was not detected, as expected, in brains of infected IFN-␥ Ϫ/Ϫ mice (Fig. 3) , nor was it detectable in brains of uninfected nude or SCID mice (data not shown). Thus, adoptive transfer of immune spleen cells prevented TE in immunodeficient animals that express IFN-␥ in the brain before receiving the immune spleen cells but not in those that did not express IFN-␥. (15, 20, 32) . In this experiment, we used SCID mice, instead of nude mice, as the recipients because the brains of nude mice may have small numbers of thymus-independent T cells. Infected SCID mice were treated with sulfadiazine and received immune spleen cells in combination with treatment with anti-asialo GM1 antibody to deplete NK cells. Histological study of the brains was performed 7 days after discontinuation of sulfadiazine. Many areas of inflammation associated with tachyzoites were observed in brains of control SCID mice that had not received immune spleen cells (Fig. 7A) . In contrast, brains of SCID mice that had received immune spleen cells with or without treatment with anti-asialo GM1 antibody exhibited no inflammatory changes or tachyzoites (P Ͻ 0.05 [ Fig. 7A]) . Depletion of NK cells in the treated mice was confirmed by the absence of NK cells in their spleens 7 days after discontinuation of sulfadiazine (Fig. 7B) . Thus, it appears that NK cells are not required for prevention of reactivation of T. gondii infection in the brain.
IFN-␥ mRNA levels in brains of infected IFN-␥
Expression of IFN-␥ in brains of infected, NK cell-depleted SCID mice. Since adoptive transfer of immune T cells conferred resistance to development of TE in NK-depleted SCID mice, we examined whether NK-depleted SCID mice express IFN-␥ in the brain before receiving immune T cells. Infected, sulfadiazine-treated SCID mice were treated with anti-asialo GM1 antibody to deplete NK cells. NK cells were undetectable by flow cytometry in brains of the NK-depleted animals at the last day of sulfadiazine treatment (proportion of NK cells in lymphocyte preparations isolated from brains of the treated versus untreated animals, Ͻ 0.1% [n ϭ 8] versus 2.0% Ϯ 1.1% [n ϭ 8]; P Ͻ 0.005). Despite the absence of NK cells in the anti-asialo GM1-treated mice, significant amounts of mRNA for IFN-␥ were detected in their brains. The amounts of the RNA did not significantly differ between the treated and untreated mice, although the mRNA detected tended to be less in the treated than untreated animals (IFN-␥/␤-actin ratio, 0.13 Ϯ 0.05 versus 0.30 Ϯ 0.18; P ϭ 0.16) (Fig. 8) . These results suggest that cells that are neither T nor NK cells express 
DISCUSSION
This study revealed that T cells require non-T cells that produce IFN-␥ to prevent reactivation of T. gondii infection in the brains in BALB/c mice. Adoptive transfer of immune spleen or T cells prevented development of TE in either athymic nude or SCID mice that had been infected and treated with sulfadiazine but not in IFN-␥ Ϫ/Ϫ mice that had been infected and treated with sulfadiazine in the same manner. Nude and SCID mice that lack T cells have previously been shown to have T-cell-independent IFN-␥ production during the acute stage of T. gondii infection, and such IFN-␥ production confers a partial resistance to the infection (15, 19, 36) . In the present study, large amounts of IFN-␥ mRNA were detected in brains of infected nude and SCID mice that had not received adoptive transfer of immune T cells but not in brains of infected IFN-␥ Ϫ/Ϫ mice. Our experiments indicate that the adoptive transfer of immune T cells conferred resistance against development of TE only in the recipient mice that express IFN-␥ in the brain before receiving the cell transfer. Thus, a combination of T cells with non-T cells that produce IFN-␥ is required for prevention of reactivation of infection in the brain. This is the first evidence of the importance of IFN-␥ production by non-T cells for resistance to T. gondii during the chronic stage of infection and for prevention of reactivation of infection.
In regard to the failure of IFN-␥ Ϫ/Ϫ mice to prevent the development of TE, this study demonstrated that spleen cells of infected IFN-␥ Ϫ/Ϫ mice did not inhibit the protective activity of the immune spleen cells. Therefore, the failure to prevent the development of TE by adoptive transfer of immune T cells in IFN-␥ Ϫ/Ϫ mice is due mostly, if not entirely, to lack of activity to produce IFN-␥ in these animals. In infected IFN-␥ Ϫ/Ϫ mice that had received immune T cells, the brain was the only organ in which large amounts of T. gondii tachyzoites were detected after discontinuation of sulfadiazine. Thus, IFN-␥-production by non-T cells that is required for T cells to prevent TE is most likely within the brain itself.
NK cells have previously been shown to produce IFN-␥ during acute infection with T. gondii (15, 20, 32) , and depletion of NK cells in SCID or immunocompetent mice by treatment with anti-asialo GM1 antibody resulted in early mortality following an acute lethal infection (15, 19) . In contrast to these There are two possible mechanisms by which T cells require non-T cells that produce IFN-␥ in the brain to prevent TE. First, immune T cells need to collaborate with IFN-␥-producing non-T cells within the brain to control the parasite. We have previously reported the requirement of IFN-␥ for genetic resistance of BALB/c mice against development of TE (37). A combination of both T and non-T cells may be required to provide sufficient amounts of IFN-␥ to control the parasite in the brain. T cells may have other functions (e.g., cytotoxic activity) besides IFN-␥ production that aid in the prevention of TE, in addition to IFN-␥ production by non-T cells. In this regards Denkers et al. (6) reported that cytotoxic activity of T cells mediated by perforin plays only a limited role in resistance to T. gondii infection in C57BL/6 mice genetically susceptible to TE. However, it is possible that the cytotoxic activity of T cells plays a more critical role in prevention of TE in genetically resistant BALB/c mice than in susceptible C57BL/6 mice, hence BALB/c mice are resistant to TE.
The second possibility is that IFN-␥ production by non-T cells in the brain is required for T cells to infiltrate the brain. Adhesion molecules on T cells and their endothelial ligands play a critical role in regulating T-cell trafficking into the organs (16, 24, 29) . IFN-␥ has been shown to induce or enhance expression of adhesion molecules on the vascular endothelial cells in vitro (8, 18) . Deckert-Schlüter et al. 
